Zepbound™ (tirzepatide) is officially available in Canada as of July 2025. Here’s what actually matters if you’re trying to get it — what it costs, where to find it, and how coverage works.
The short version
- Available in Canadian pharmacies starting July 10, 2025
- Costs ~$300–$550/month uninsured, or as low as $1–$2/day with insurance
- Myzepbound™ support program helps reduce costs for eligible Canadians
Is Zepbound Available in Canada?
Yes. Health Canada authorized it in May 2025, and it reached pharmacies nationwide that July.
Pharmacies in Ontario, Quebec, BC, Alberta, and other provinces can order Zepbound through distributors like McKesson.
What Is Zepbound?
Zepbound is a weekly injection and requires a prescription in Canada.
Zepbound Cost in Canada
How much does Zepbound cost in Canada?
The cost of Zepbound depends on your insurance coverage, and whether you’re enrolled in the Myzepbound support program.
What if I don’t have insurance coverage for Zepbound?
If you’re uninsured, the retail cost of Zepbound in Canada is expected to range from $300 to $690 per month.
But here’s the good news: if you don’t have insurance, you could still save 10–25% off the retail price by enrolling in the Myzepbound™ patient support program. That means instead of paying up to $690/month, you could pay closer to $300–$550/month—a savings of up to $171/month or more. These figures are based on early program information and are still being confirmed by Eli Lilly Canada at this time.
How much co-pay can I expect for Zepbound with insurance?
If you have private insurance, and your plan covers medications in this category, you may be eligible for co-pays as low as $1–$2 per day, or about $30–$60 per month. This lower price typically comes through the Myzepbound patient support program, which helps reduce insured patients’ out-of-pocket costs.
Is there any cash discounts or savings program for Zepbound if paying out-of-pocket?
If you’re paying cash, Myzepbound also offers a savings card for eligible patients. This must be applied before the purchase—pharmacies cannot apply it retroactively or offer refunds after you pay.
Key points:
- Out-of-pocket (uninsured): ~$300–$700/month
- Insured (with Myzepbound): as low as $30–$90/month
- Savings card available for eligible cash-pay patients
- Cost varies by dose and pharmacy
- Zepbound is not yet covered by public drug plans in most provinces, but may be reimbursed by some private/employer plans.
What Is the Myzepbound™ Patient Support Program?
The Myzepbound™ program is Eli Lilly Canada’s official patient support system designed to make Zepbound more affordable and accessible for Canadians. It helps both insured and uninsured patients lower their out-of-pocket costs and access prescription support. Here’s what the program offers:
- Co-pay reduction for insured patients: If you have private insurance and your plan covers Zepbound, the program may reduce your cost to as little as $1–$3 per day (roughly $30–$90 per month).
- Savings card for cash-pay patients: If you’re paying out of pocket, you may qualify for a savings card that applies a discount at the time of purchase.
Note: The savings card must be applied before purchase — it cannot be used for reimbursement afterward.
- Support with insurance paperwork: The program can assist your doctor in submitting prior authorizations and navigating coverage appeals with your insurance provider.
Update on discontinued perk: The Myzepbound™ program previously included a unique incentive — if you were paying out of pocket and using doses of 5 mg or higher, every 7th dose was free. This was provided through a voucher system and reset after each set of six qualifying doses. This program has now been discontinued, and Elli Lilly Canada has directly increased the monthly savings available under the PSP to a maximum of $171.42. The final price of each 12.5mg or 15.0mg injector will vary by pharmacy. With Cloudcure patients participating in the Myzepbound™ PSP could pay as low as $518.58, while still enjoying free express shipping to their door.
Need more help? Ask your clinic or prescriber how to enroll, or visit Myzepbound for registration.
Where to Buy Zepbound in Canada
If you’re wondering where to get Zepbound in Canada, here’s how to access it today:
- Visit your local pharmacy: Most pharmacies across Canada can order Zepbound through major distributors like McKesson. You may need a couple of days for it to arrive if they don’t stock it yet, but it is now available to order nationwide.
- Ask your doctor for a prescription: Zepbound is a prescription-only medication. Your family doctor, endocrinologist, or specialist can prescribe Zepbound for you.
- Use a virtual care provider: Reputable clinics like Cloudcure and other licensed telehealth providers can assess you online and prescribe Zepbound remotely. This is a convenient option if you don’t have a regular primary care provider or want convenient access to their Zepbound prescription.
- Enroll in Myzepbound: Wherever you get your prescription, make sure you ask about the Myzepbound support program to help lower your cost. Most clinics can enroll you at the time of prescribing.
Helpful tip: Be sure to check with the pharmacy in advance to confirm inventory or request a special order if needed. Most major chains (Shoppers Drug Mart, Rexall, Guardian, etc.) can source Zepbound easily now.
Talk to your doctor or reach out to a licensed provider today to get your Zepbound prescription.
Disclaimer: This blog is intended for informational purposes and should not be considered a substitute for professional medical advice. Consult with your healthcare provider to determine the most suitable treatment options tailored to your unique needs.
Health Canada–Regulated Product Information
This section contains clinical information about Zepbound™ (tirzepatide) from the Health Canada product monograph. To view, enter the Health Canada Drug Identification Number (DIN) for Zepbound. DINs are publicly available in the Health Canada Drug Product Database.
Invalid DIN. Please verify the DIN at the Health Canada Drug Product Database.
Zepbound™ (tirzepatide) — Product Information
Zepbound™ (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by Health Canada as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.
Health Canada–Authorized Indication
Zepbound is indicated for chronic weight management in adults with:
- A body mass index (BMI) of ≥30 kg/m² (obesity), or
- A BMI of ≥27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea
How Zepbound Works
Zepbound activates both GIP and GLP-1 receptors, reducing appetite, slowing gastric emptying, and improving insulin sensitivity. This dual-receptor mechanism differentiates Zepbound from single-agonist GLP-1 medications.
Clinical Results — SURMOUNT-1 Trial
In the SURMOUNT-1 phase 3 trial (n=2,539 adults with obesity or overweight plus comorbidities, without type 2 diabetes):
- Participants on 15 mg tirzepatide lost an average of 20.9% of body weight over 72 weeks vs 3.1% on placebo
- 57% of participants on 15 mg achieved ≥20% weight loss
Source: Jastreboff et al., N Engl J Med 2022. Individual results vary.
Available Doses in Canada
| Dose | Role |
|---|---|
| 2.5 mg/week | Starting dose (first 4 weeks) |
| 5 mg/week | Maintenance or titration |
| 7.5 mg/week | Titration |
| 10 mg/week | Titration |
| 12.5 mg/week | Maintenance |
| 15 mg/week | Maximum dose |
Common Side Effects
Most common (≥5% of patients): nausea, diarrhea, vomiting, constipation, abdominal pain, injection site reactions. Most occur during dose titration and typically decrease over time. Consult your healthcare provider for guidance on managing side effects.
Is Zepbound Appropriate for You?
Whether Zepbound is a fit comes down to your BMI and weight-related health conditions, which a licensed provider reviews with you. Book a Cloudcure consultation to speak with a provider who can review your eligibility and, if appropriate, prescribe Zepbound with Myzepbound™ enrollment support.
This product information is based on the Health Canada–approved product monograph for Zepbound™ (tirzepatide). Health Canada DINs: 02557509, 02557517, 02557525, 02557533, 02557541, 02557568. Last reviewed: June 2026.